Peer-influenced content. Sources you trust. No registration required. This is HCN.

Schizophrenia Bulletin:The Journal of Psychoses and Related Disorders

Schizophrenia Bulletin seeks to publish recent developments and empirically based hypotheses regarding the etiology, pathophysiology and treatment of schizophrenia and related disorders. We view the field as broad and deep and will publish new knowledge ranging from molecular to social and cultural factors. We will give new emphasis to translational reports which simultaneously highlight basic neurobiological mechanisms and clinical manifestations. Some of the Bulletin content is invited as special features or manuscripts organized as a theme by special guest editors. Most pages of the Bulletin are devoted to unsolicited manuscripts of high quality that report original data or where we can provide a special venue for a major study or workshop report. Supplement issues are sometimes arranged for reports from a recent conference or proposed to highlight a specific area.

The editorial policy of the Schizophrenia Bulletin generally follows the Uniform Requirements guidelines articulated by the International Committee of Medical Journal Editors. The journal publishes six issue a year and has an international readership.

The Bulletin is an ideal venue for special reports such as treatment guidelines or changes in nosology. The Bulletin will publish At Issue articles expressing opposing views on controversial scientific issues, succinct discourses on clinical and basic neuroscience concepts, and brief essays on the role of specific environmental and genetic factors in schizophrenia. Schizophrenia Bulletin will continue the tradition of the front cover display of art from artists with mental illness and first person accounts informing on the lived experience of psychosis.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form